Literature DB >> 19549592

New aspects of rapid aldosterone signaling.

C Grossmann1, M Gekle.   

Abstract

Aldosterone, the endogenous ligand of the mineralocorticoid receptor (MR) in humans, is a steroid hormone that regulates salt and water homeostasis. Recently, additional pathophysiological effects in the renocardiovascular system have been identified. Besides genomic effects mediated by activated MR, rapid aldosterone actions that are independent of translation and transcription have been documented. While these nongenomic actions influence electrolyte homeostasis, pH and cell volume in classical MR target organs, they also participate in pathophysiological effects in the renocardiovascular system causing endothelial dysfunction, inflammation and remodeling. The mechanisms conveying these rapid effects consist of a multitude of signaling molecules and include a cross-talk with genomic aldosterone effects as well as with angiotensin II and epidermal growth factor receptor signaling. Rapid corticosteroid signaling via the MR has also been demonstrated in the brain. Altogether, the function of nongenomic aldosterone effects seems to be to modulate other signaling cascades, depending on the surrounding milieu.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19549592     DOI: 10.1016/j.mce.2009.02.005

Source DB:  PubMed          Journal:  Mol Cell Endocrinol        ISSN: 0303-7207            Impact factor:   4.102


  47 in total

1.  Variants in striatin gene are associated with salt-sensitive blood pressure in mice and humans.

Authors:  Amanda E Garza; Chevon M Rariy; Bei Sun; Jonathan Williams; Jessica Lasky-Su; Rene Baudrand; Tham Yao; Burhanuddin Moize; Wan M Hafiz; Jose R Romero; Gail K Adler; Claudio Ferri; Paul N Hopkins; Luminita H Pojoga; Gordon H Williams
Journal:  Hypertension       Date:  2014-11-03       Impact factor: 10.190

2.  The protective side of the mineralocorticoid receptor.

Authors:  Celso E Gomez-Sanchez; Elise P Gomez-Sanchez
Journal:  Endocrinology       Date:  2012-03-09       Impact factor: 4.736

3.  Regulation of WNK1 expression by miR-192 and aldosterone.

Authors:  Emilie Elvira-Matelot; Xiao-ou Zhou; Nicolette Farman; Geneviève Beaurain; Alexandra Henrion-Caude; Juliette Hadchouel; Xavier Jeunemaitre
Journal:  J Am Soc Nephrol       Date:  2010-09-02       Impact factor: 10.121

4.  Aldosterone stimulates vacuolar H(+)-ATPase activity in renal acid-secretory intercalated cells mainly via a protein kinase C-dependent pathway.

Authors:  Christian Winter; Nicole B Kampik; Luca Vedovelli; Florina Rothenberger; Teodor G Paunescu; Paul A Stehberger; Dennis Brown; Hubert John; Carsten A Wagner
Journal:  Am J Physiol Cell Physiol       Date:  2011-08-10       Impact factor: 4.249

Review 5.  The role of ENaC in vascular endothelium.

Authors:  Kristina Kusche-Vihrog; Pia Jeggle; Hans Oberleithner
Journal:  Pflugers Arch       Date:  2013-09-18       Impact factor: 3.657

6.  Direct control of Na(+)-K(+)-2Cl(-)-cotransport protein (NKCC1) expression with aldosterone.

Authors:  Bo Ding; Robert D Frisina; Xiaoxia Zhu; Yoshihisa Sakai; Bernd Sokolowski; Joseph P Walton
Journal:  Am J Physiol Cell Physiol       Date:  2013-10-30       Impact factor: 4.249

7.  Characterization of two mammalian cortical collecting duct cell lines with hopping probe ion conductance microscopy.

Authors:  Xuewei Chen; Hui Zhu; Xiao Liu; Hujie Lu; Ying Li; Jing Wang; Hongtao Liu; Jianning Zhang; Qiang Ma; Yanjun Zhang
Journal:  J Membr Biol       Date:  2012-09-09       Impact factor: 1.843

Review 8.  Angiotensin II AT(1) receptor blockers as treatments for inflammatory brain disorders.

Authors:  Juan M Saavedra
Journal:  Clin Sci (Lond)       Date:  2012-11       Impact factor: 6.124

Review 9.  The multifaceted mineralocorticoid receptor.

Authors:  Elise Gomez-Sanchez; Celso E Gomez-Sanchez
Journal:  Compr Physiol       Date:  2014-07       Impact factor: 9.090

Review 10.  Genomic and rapid effects of aldosterone: what we know and do not know thus far.

Authors:  Milla Marques Hermidorff; Leonardo Vinícius Monteiro de Assis; Mauro César Isoldi
Journal:  Heart Fail Rev       Date:  2017-01       Impact factor: 4.214

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.